<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04984915</url>
  </required_header>
  <id_info>
    <org_study_id>2021075</org_study_id>
    <nct_id>NCT04984915</nct_id>
  </id_info>
  <brief_title>The Usefulness of CaIMR in Patients With STEMI</brief_title>
  <official_title>The Long-term Prognostic Value of CaIMR in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongnan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongnan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The coronary artery system is composed of three different types of blood vessels, namely&#xD;
      epicardial arteries, arterioles and capillaries. Compared with epicardial arteries,&#xD;
      arterioles and capillaries are lower than the resolution of current angiography systems, so&#xD;
      angiography cannot be used for visualization. Existing studies have shown that coronary&#xD;
      microcirculation plays an extremely important role in maintaining full myocardial perfusion.&#xD;
      Coronary microvascular disorders can lead to myocardial hypoperfusion and ischemia, and are&#xD;
      related to the poor prognosis of patients with coronary heart disease. At present, there is&#xD;
      no technology that can directly detect the state of the coronary microcirculation in the&#xD;
      human body, but the coronary microcirculation function can be indirectly assessed through two&#xD;
      invasive and non-invasive methods. Among them, the index of microcirculation resistance (IMR)&#xD;
      is widely used to evaluate coronary microcirculation function [3]. However, in the case of&#xD;
      epicardial stenosis, accurate determination of IMR requires knowledge of coronary artery&#xD;
      contraction pressure (Pw). However, measuring IMR is an invasive examination technique, and&#xD;
      measuring IMR requires high technical requirements for the operator. Therefore, the CaIMR&#xD;
      value obtained by AI technology can well overcome this limitation, and the existing data show&#xD;
      that the CaIMR value has a good correlation with the IMR value. However, CaIMR has a clinical&#xD;
      prognosis for patients with acute ST-segment elevation myocardial infarction. The predictive&#xD;
      value of CaIMR has not yet been explored. This project aims to evaluate the application value&#xD;
      of CaIMR in predicting the occurrence of adverse cardiovascular events in patients with acute&#xD;
      ST-segment elevation myocardial infarction after percutaneous coronary intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The composite endpoint of all-cause death and heart failure rehospitalization</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>The composite endpoint of all-cause death and heart failure rehospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The composite endpoint of all-cause death and heart failure rehospitalization</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>The composite endpoint of all-cause death and heart failure rehospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>All-cause death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>All-cause death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure rehospitalization</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Heart failure rehospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure rehospitalization</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>Heart failure rehospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiogenic Rehospitalization</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Cardiogenic Rehospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiogenic Rehospitalization</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>Cardiogenic Rehospitalization</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>CaIMR</condition>
  <condition>Prognosis</condition>
  <condition>ST-segment Elevation Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who meet the inclusion and exclusion criteria are included in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who are clinically diagnosed with acute ST-segment elevation myocardial&#xD;
             infarction and are planned to undergo PCI;&#xD;
&#xD;
          -  Volunteer to participate and sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coronary angiography suggests that it is not suitable for PCI;&#xD;
&#xD;
          -  Have performed CABG surgery in the past;&#xD;
&#xD;
          -  Lesion of left or right coronary ostium;&#xD;
&#xD;
          -  The target vessel is an infarct-related artery (old or acute myocardial infarction&#xD;
             recovery period);&#xD;
&#xD;
          -  The immediate effect of target vessel PCI is not ideal (such as: final TIMI blood flow&#xD;
             &lt;grade 3, dissection with restricted blood flow, side branch occlusion with diameter&gt;&#xD;
             1.5 mm, distal embolism or thrombus shown by angiography);&#xD;
&#xD;
          -  Severe systemic infection;&#xD;
&#xD;
          -  Patients with malignant wasting disease whose estimated survival time is less than 1&#xD;
             year.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhibing Lu, MD, PhD</last_name>
    <phone>8615997405817</phone>
    <email>luzhibing222@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongnan Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430071</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Lei Zheng, PhD</last_name>
      <phone>027-67812787</phone>
      <email>znyyll@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhongnan Hospital</investigator_affiliation>
    <investigator_full_name>Zhibing Lu</investigator_full_name>
    <investigator_title>The chief of cardiology department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

